Nolato AB (publ) - Asset Resilience Ratio
Nolato AB (publ) (NOLA-B) has an Asset Resilience Ratio of 5.19% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check NOLA-B strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2025)
This chart shows how Nolato AB (publ)'s Asset Resilience Ratio has changed over time. See NOLA-B net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Nolato AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NOLA-B company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr482.00 Million | 5.19% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr482.00 Million | 5.19% |
Asset Resilience Insights
- Limited Liquidity: Nolato AB (publ) maintains only 5.19% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Nolato AB (publ) Industry Peers by Asset Resilience Ratio
Compare Nolato AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
Annual Asset Resilience Ratio for Nolato AB (publ) (2009–2025)
The table below shows the annual Asset Resilience Ratio data for Nolato AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.19% | Skr482.00 Million ≈ $51.87 Million |
Skr9.28 Billion ≈ $998.89 Million |
-1.77pp |
| 2024-12-31 | 6.97% | Skr675.00 Million ≈ $72.64 Million |
Skr9.69 Billion ≈ $1.04 Billion |
-0.57pp |
| 2023-12-31 | 7.54% | Skr701.00 Million ≈ $75.44 Million |
Skr9.30 Billion ≈ $1.00 Billion |
-2.61pp |
| 2022-12-31 | 10.14% | Skr1.01 Billion ≈ $109.23 Million |
Skr10.01 Billion ≈ $1.08 Billion |
-4.27pp |
| 2021-12-31 | 14.41% | Skr1.45 Billion ≈ $155.94 Million |
Skr10.05 Billion ≈ $1.08 Billion |
-3.02pp |
| 2020-12-31 | 17.43% | Skr1.51 Billion ≈ $162.93 Million |
Skr8.68 Billion ≈ $934.54 Million |
-4.85pp |
| 2019-12-31 | 22.29% | Skr1.37 Billion ≈ $147.11 Million |
Skr6.13 Billion ≈ $660.12 Million |
+3.71pp |
| 2018-12-31 | 18.58% | Skr958.00 Million ≈ $103.10 Million |
Skr5.16 Billion ≈ $554.87 Million |
+4.33pp |
| 2017-12-31 | 14.25% | Skr677.00 Million ≈ $72.86 Million |
Skr4.75 Billion ≈ $511.39 Million |
+3.52pp |
| 2016-12-31 | 10.73% | Skr421.00 Million ≈ $45.31 Million |
Skr3.92 Billion ≈ $422.29 Million |
+10.51pp |
| 2015-12-31 | 0.22% | Skr7.00 Million ≈ $753.31K |
Skr3.23 Billion ≈ $347.92 Million |
-17.53pp |
| 2009-12-31 | 17.75% | Skr375.00 Million ≈ $40.36 Million |
Skr2.11 Billion ≈ $227.39 Million |
-- |
About Nolato AB (publ)
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more